Packaged Medicaments in United States

EXPORTS (2018): $25.4B, World Rnk 5 / 190
Flag Rnk 9 / 1222

TOP DESTINATION (2018): $3.51B, Belgium-Luxembourg

FASTEST GROWING MARKET (2017 - 2018): $1.03B, United Kingdom

IMPORTS (2018): $71.3B, World Rnk 1 / 217
Flag Rnk 6 / 1217

TOP ORIGIN (2018): $13.2B, Switzerland

FASTEST GROWING ORIGIN (2017 - 2018): $2.86B, Switzerland

ECONOMIC COMPLEXITY of United States (2018): 1.57, Rnk 9 / 137

PRODUCT COMPLEXITY  IN Packaged Medicaments (2018): 0.74, Rnk 270 / 1018

Overview: This page contains the latest trade data of Packaged Medicaments in United States.

Exports: In 2018, United States exported $25.4B in Packaged Medicaments, making it the 5th largest exporter of Packaged Medicaments in the world. At the same year, Packaged Medicaments was the 9th most exported product in United States. The main destination of Packaged Medicaments exports from United States are: Belgium-Luxembourg ($3.51B), United Kingdom ($2.22B), Canada ($2.16B), Japan ($2.05B), and Germany ($1.53B).

The fastest growing export markets for Packaged Medicaments of United States between 2017 and 2018 were United Kingdom ($1.03B), Netherlands ($679M), and Australia ($538M).

Imports: In 2018, United States imported $71.3B in Packaged Medicaments, becoming the 1st largest importer of Packaged Medicaments in the world. At the same year, Packaged Medicaments was the 6th most imported product in United States. United States imports Packaged Medicaments primarily from: Switzerland ($13.2B), Ireland ($11.2B), Germany ($11.2B), India ($5.5B), and Canada ($4.39B).

The fastest growing import markets in Packaged Medicaments for United States between 2017 and 2018 were Switzerland ($2.86B), Belgium-Luxembourg ($2.31B), and Germany ($1.67B).

Overview: In August 2020 United States' Packaged Medicaments exports accounted up to $1.94B and imports accounted up to $6.63B, resulting in a negative trade balance of $4.69B. Between August 2019 and August 2020 the exports of United States'   Packaged Medicaments have decreased by $-148M (-7.1%) from $2.09B to $1.94B, while imports decreased by $-305M (-4.4%) from $6.94B to $6.63B.

Destinations: In August 2020 Packaged Medicaments exported mostly to Canada ($240M), China ($227M), Belgium ($199M), Japan ($148M), and United Kingdom ($146M), and imported mostly from Switzerland ($1.75B), Ireland ($868M), India ($675M), Germany ($544M), and Denmark ($460M).

Growth: In August 2020, the decrease in Packaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to Germany ($-113M or -48.9%), Japan ($-89.6M or -37.7%), and Spain ($-76.5M or -49.3%). In August 2020, the decrease in Packaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Ireland ($-701M or -44.7%), Germany ($-252M or -31.6%), and Italy ($-181M or -30.9%).

Subnational Monthly Trade

#permalink to section
Flow
Value

EXPORT GROWTH (August 2019 - August 2020): $-148M, (-7.1%)

IMPORT GROWTH (August 2019 - August 2020): $-305M, (-4.4%)

MAIN EXPORTER (August 2020): Puerto Rico, $523M

MAIN DESTINATION (August 2020): Canada, $240M

This section shows Packaged Medicaments's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Packaged Medicaments over time.

Value

EXPORTS (2018): $25.4B

IMPORTS (2018): $71.3B

NET TRADE (2018): -$45.9B

In 2018, United States exported $25.4B in Packaged Medicaments. The main destinations of United States exports on Packaged Medicaments were Belgium-Luxembourg ($3.51B), United Kingdom ($2.22B), Canada ($2.16B), Japan ($2.05B), and Germany ($1.53B).

In 2018, United States imported $71.3B in Packaged Medicaments, mainly from Switzerland ($13.2B), Ireland ($11.2B), Germany ($11.2B), India ($5.5B), and Canada ($4.39B).

Explore Visualizations

IN 2018, United States HAD A POSITIVE NET TRADE IN Packaged Medicaments WITH:

  • China, $1.06B ($1.48B - $427M)
  • Spain, $1.06B ($1.42B - $367M)
  • Netherlands, $940M ($1.32B - $384M)

IN 2018, United States HAD A NEGATIVE NET TRADE IN Packaged Medicaments WITH:

  • Switzerland, -$12.4B ($827M - $13.2B)
  • Ireland, -$10.6B ($656M - $11.2B)
  • Germany, -$9.67B ($1.53B - $11.2B)
Flow

THE FASTEST GROWING Packaged Medicaments EXPORT MARKETS FOR United States WERE (2017 - 2018):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Packaged Medicaments BY United States WERE (2017 - 2018):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2018, United States's main exporting competitors in Packaged Medicaments were:

In 2018, United States's main importing competitors in Packaged Medicaments were:

Explore Visualizations

Trade Forecasts

#permalink to section

Time

This section shows forecasts for total exports and imports, for Packaged Medicaments in United States. The forecast is based on a short-term, medium-term and long-term model using yearly trade data.

Explore Forecasts

Tariffs by Country

#permalink to section

In 2017, the tariffs for Packaged Medicaments in the imports of United States were of 0% around the world.

Explore Tariff Data